KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
AcquisitionsAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)Depreciation and DepletionDivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bristol Myers Squibb (BMY) Other Working Capital Changes (2016 - 2025)

Historic Other Working Capital Changes for Bristol Myers Squibb (BMY) over the last 17 years, with Q4 2025 value amounting to -$1.1 billion.

  • Bristol Myers Squibb's Other Working Capital Changes fell 4731.03% to -$1.1 billion in Q4 2025 from the same period last year, while for Dec 2025 it was -$471.0 million, marking a year-over-year increase of 2451.92%. This contributed to the annual value of -$471.0 million for FY2025, which is 2451.92% up from last year.
  • As of Q4 2025, Bristol Myers Squibb's Other Working Capital Changes stood at -$1.1 billion, which was down 4731.03% from -$240.0 million recorded in Q3 2025.
  • Over the past 5 years, Bristol Myers Squibb's Other Working Capital Changes peaked at $1.1 billion during Q1 2022, and registered a low of -$1.1 billion during Q4 2025.
  • Over the past 5 years, Bristol Myers Squibb's median Other Working Capital Changes value was -$170.0 million (recorded in 2023), while the average stood at $22.3 million.
  • As far as peak fluctuations go, Bristol Myers Squibb's Other Working Capital Changes soared by 18526.79% in 2022, and later tumbled by 38305.08% in 2024.
  • Over the past 5 years, Bristol Myers Squibb's Other Working Capital Changes (Quarter) stood at -$272.0 million in 2021, then plummeted by 157.35% to -$700.0 million in 2022, then skyrocketed by 59.57% to -$283.0 million in 2023, then tumbled by 156.18% to -$725.0 million in 2024, then plummeted by 47.31% to -$1.1 billion in 2025.
  • Its Other Working Capital Changes stands at -$1.1 billion for Q4 2025, versus -$240.0 million for Q3 2025 and -$222.0 million for Q2 2025.